Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
47
Employees47
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
47
Employees47

LGND Key Statistics

Market cap
4.65B
Market cap4.65B
Price-Earnings ratio
37.88
Price-Earnings ratio37.88
Dividend yield
Dividend yield
Average volume
198.69K
Average volume198.69K
High today
$233.06
High today$233.06
Low today
$228.36
Low today$228.36
Open price
$228.36
Open price$228.36
Volume
105.66K
Volume105.66K
52 Week high
$247.38
52 Week high$247.38
52 Week low
$98.89
52 Week low$98.89

Stock Snapshot

As of today, Ligand Pharmaceuticals(LGND) shares are valued at $232.30. The company's market cap stands at 4.65B, with a P/E ratio of 37.88.

During the trading session on 2026-05-06, Ligand Pharmaceuticals(LGND) shares reached a daily high of $233.06 and a low of $228.36. At a current price of $232.30, the stock is +1.7% higher than the low and still -0.3% under the high.

Trading activity shows a volume of 105.66K, compared to an average daily volume of 198.69K.

The stock's 52-week range extends from a low of $98.89 to a high of $247.38.

The stock's 52-week range extends from a low of $98.89 to a high of $247.38.

LGND News

Simply Wall St 4h
Did Higher 2026 Guidance and XOMA Deal Just Shift Ligand Pharmaceuticals' Investment Narrative?

Ligand Pharmaceuticals recently raised its 2026 revenue guidance to a range of US$270 million to US$310 million and discussed its planned acquisition of XOMA Ro...

Did Higher 2026 Guidance and XOMA Deal Just Shift Ligand Pharmaceuticals' Investment Narrative?

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.